Skip to main content
Scott Irwin, MD, Psychiatry, Los Angeles, CA, Cedars-Sinai Medical Center

ScottAIrwinMDPhD

Psychiatry Los Angeles, CA

Psychosomatic Medicine

Director Patient and Family Support Program and Professor of Psychiatry and Behavioral Neurosciences; Cedars-Sinai Health System, Cedars-Sinai Cancer, and Department of Psychiatry and Behavioral Neurosciences

Dr. Irwin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Irwin's full profile

Already have an account?

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Psychiatry, 2002 - 2006
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2002
  • University of Illinois at Urbana-Champaign
    University of Illinois at Urbana-ChampaignPhD, Neuroanatomy, 2000
  • University of California, Los Angeles
    University of California, Los AngelesBS, Psychobiology, 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2003 - 2025
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Consultation-Liaison Psychiatry

Awards, Honors, & Recognition

  • Scholar Advanced Research Institute in Geriatric Mental Health, 2014
  • Visiting Professorship Program Award Academy of Psychosomatic Medicine, 2011
  • Honoree, Health Care Champion Awards for Innovation and Research San Diego Business Journal, 2010
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • What did I miss? A qualitative assessment of the impact of patient suicide on hospice clinical staff  
    Fairman N, Montross LP, Whitmore S, Meier E, Irwin SA, Journal of Palliative Medicine, 1/1/2014
  • Caregiving at the end-of-life  
    Pottie, C.G., Montross-Thomas, L., Burch, K.A., and Irwin, S.A, Journal of Palliative Medicine, 1/1/2014
  • Association Between Hospice Care and Psychological Outcomes in Alzheimer’s Family Caregivers  
    Irwin, S.A., Mausbach, B.T., Koo, D., Fairman, N., Roepke, S.K., Chattillion, E.A., Dimsdale, J.E., Patterson, T.L., Ancoli-Israel, S., Mills, P.J., von Kanel, R., Zie..., Journal of Palliative Medicine, 1/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Hospice Women’s Reflections on Wisdom: A Qualitative Case Series
    Marrone, L., Montross, L., Jeste, D., Irwin, S.A., Holzer, J., Moore, K., Rivas, T., and De Cervantes-Montheith, American Association of Geriatric Psychiatry, 1/1/2014
  • Ketamine for the Management of Depression in Palliative Care: An Update on the Science
    Irwin, S.A., Hirst, J., Fairman, N., and Prommer E, American Academy of Hospice and Palliative Medicine Annual Meeting, 3/1/2013
  • A Retrospective Chart Review of the Use of Ketamine to Treat Depression in Hospice Patients
    Morrison, K., Iglewicz, A., and Irwin, S.A, American Academy of Hospice and Palliative Medicine Annual Meeting, 3/1/2013
  • Join now to see all

Lectures

  • Geriatrics Career Panel 
    La Jolla, CA - 7/30/2014
  • Clinical Challenges with Depression Comorbidities and the Palliative Care Patient 
    Los Angeles, CA - 2/25/2014
  • The Opportunity for Healthcare via Palliative Care 
    San Diego, CA - 1/23/2014
  • Join now to see all

Press Mentions

  • ABVC BioPharma Provides ABV-1601 Update on Phase I Site Initiation Visit Conducted at Cedars-Sinai Medical Center (CSMC)
    ABVC BioPharma Provides ABV-1601 Update on Phase I Site Initiation Visit Conducted at Cedars-Sinai Medical Center (CSMC)April 10th, 2023
  • Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer Patients
    Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer PatientsNovember 2nd, 2022
  • Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer Patients
    Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer PatientsNovember 2nd, 2022
  • Join now to see all

Grant Support

  • Improving Psychiatric Interventions At The END Of LifeNational Institute Of Mental Health2010–2011
  • Expression And Function Of FMRP During DevelopmentNational Institute Of Mental Health1996–2002

Hospital Affiliations